U.S. Logistics Stock News

On June 27, 2026, Acadia Healthcare Company was removed from the Russell 1000, Midcap and related value/dynamic benchmarks, while being added to the Russell 2000 Index and its value and dynamic counterparts as part of the Russell index reconstitution. This shift effectively recategorizes Acadia Healthcare into the smaller‑capitalization value universe, which can alter its investor base, trading liquidity and how portfolio managers frame its role within behavioral health exposure. Next, we’ll...

MasTec, Inc. recently added veteran utility executive Manny Miranda to its Board as a Class II Director, while the company was also removed from several Russell value and growth benchmarks in late June 2026. His four decades of hands-on experience in electric and natural gas utility operations could deepen MasTec’s insight into grid modernization and energy infrastructure challenges. With Miranda’s utility expertise now on the board, we’ll examine how these developments may influence...

Index removal puts Axos Financial in focus Axos Financial (AX) has come under closer watch after being dropped from the Russell 2000 Dynamic Index, a shift that can prompt trading changes as index-tracking funds rebalance their portfolios. See our latest analysis for Axos Financial. The Russell 2000 Dynamic Index exit arrives at a time when Axos Financial’s recent momentum has been positive, with a 30 day share price return of 14.58% and a 1 year total shareholder return of 18.95%, alongside...

Advanced Energy Industries (AEIS) has been catching investor attention after a sharp move in the stock, supported by strong sector momentum, upbeat semiconductor spending forecasts, recent Russell index inclusions, and activity around new AI data center products. See our latest analysis for Advanced Energy Industries. The share price of Advanced Energy Industries has eased 4.4% over the last day and is roughly flat over the past week. However, a 20.9% 1 month share price return and 60.5% year...

Index inclusions put Genius Sports in focus Genius Sports (GENI) is drawing fresh investor attention after being added to several Russell value indices, including the Russell 2000 Value and 2500 Value benchmarks, a shift that can influence institutional demand. See our latest analysis for Genius Sports. The index inclusions arrive after a sharp 39.47% 90 day share price return and a 12.37% 7 day share price return, set against a year to date share price decline of 41% and a 1 year total...

Sensient Technologies recently entered into a new unsecured delayed-draw term loan credit facility of up to US$400,000,000, maturing in five years, to refinance existing debt and support working capital and other general corporate purposes. The agreement’s flexible draw structure, leverage and interest coverage covenants, and option to prepay without penalty could meaningfully influence Sensient’s balance sheet management and funding costs. We’ll now examine how this US$400,000,000...

ACV Auctions (ACVA) was added to several Russell value and small cap benchmarks, including the Russell 2000 Value and Russell 3000 Value indices. This shift can influence index fund activity and overall investor attention. See our latest analysis for ACV Auctions. ACV Auctions' inclusion in several Russell value indices comes after a sharp 67.2% 3 month share price return to US$7.29, even though the year to date share price return is down 12.06% and the 1 year total shareholder return has...

In late June 2026, JPMorgan upgraded its rating on Qualys after reassessing the company’s position in the expanding vulnerability management segment and broader cybersecurity services market. This reassessment highlights how Qualys’ core role in helping enterprises proactively identify and prioritize security risks is becoming more central as organizations modernize their defenses. We’ll now explore how this renewed confidence in Qualys’ vulnerability management strength may influence its...

PROCEPT BioRobotics (PRCT) drew fresh attention after Evercore ISI initiated coverage, alongside two new Aquablation milestones: full enrollment in the WATER IV RP trial and FDA IDE approval for a second prostate cancer study. See our latest analysis for PROCEPT BioRobotics. At a share price of US$23.47, PROCEPT BioRobotics has seen a 7 day share price return of 12.57% following the Evercore ISI coverage and clinical milestones, but this sits against a 1 year total shareholder return that...

Interparfums (IPAR) has drawn fresh attention after a session where the stock rose 3.4% to $115.67, helped by investor focus on its high gross margins, solid free cash flow, and recent outperformance. See our latest analysis for Interparfums. The recent 3.4% one day share price return and 10.9% 7 day share price return sit on top of a 25.2% 30 day share price return and 35.4% year to date share price return. In contrast, the 1 year total shareholder return is down 12.9% and the 3 year total...

Horizon Bancorp recently recorded an approximate US$3.0 million pre-tax reserve after a June 24, 2026 jury awarded nearly US$3.0 million in damages against its Horizon Bank subsidiary over a 2018 indirect auto repossession and credit reporting dispute, and the company has said it plans to appeal the punitive component. An interesting wrinkle for investors is that Horizon had already exited most of its indirect auto lending exposure by 2024, and now characterizes the verdict as isolated with...

Dole (NYSE:DOLE) has closed the sale of its port and port operations in Guayaquil, Ecuador, to TIL Switzerland Sàrl, receiving about US$75 million in cash after costs and transaction adjustments. See our latest analysis for Dole. Dole’s latest port sale comes after a period where the share price has eased, with the 90 day share price return down 5.7% and the year to date share price return down 6.15%. The 3 year total shareholder return is 12.26%, suggesting longer term holders have seen...

On 27 June 2026, Bowhead Specialty Holdings Inc. (NYSE: BOW) was reclassified across Russell indices, moving from growth benchmarks into several value-focused indices including the Russell 3000 Value and Russell 2000 Value. This shift in index membership highlights how the market now groups Bowhead more with value-oriented insurers, potentially affecting which institutional investors track or hold the stock. Next, we'll examine how this reclassification toward value indices interacts with...

Live Nation Entertainment (LYV) is back in focus after a multi-year partnership with Lowe's tied the concert giant to the retailer's loyalty program, while investors also weigh strong demand signals and unresolved antitrust remedies. See our latest analysis for Live Nation Entertainment. At a share price of $183.98, Live Nation Entertainment has seen momentum build over recent months, with a 30-day share price return of 7.94% and a 90-day gain of 18.13%. The 5-year total shareholder return of...

Investors who take an interest in ProQR Therapeutics N.V. ( NASDAQ:PRQR ) should definitely note that the Independent...

Some Broadcom Inc. ( NASDAQ:AVGO ) shareholders may be a little concerned to see that the Chief Legal & Corporate...

Some Telos Corporation ( NASDAQ:TLS ) shareholders may be a little concerned to see that the Executive VP & CFO, Gary...

US dividend growth stocks sit at the crossroads of confident sentiment, long-running economic resilience, and rising inflation risk. With many investors now more focused on staying invested than fearing the next downturn, companies that have grown dividends by at least 2% a year can look appealing as a potential source of cash flow discipline. At the same time, any sharp correction or policy shock could test how durable those payouts really are. This article walks through three stocks exposed...

Crown Castle (NYSE:CCI) is advancing its plan to become a pure-play tower REIT. The company is pursuing the sale of its fiber and small-cell business as part of this shift. Recent executive leadership changes are aligned with the new tower-focused strategy. Crown Castle operates wireless towers and related infrastructure that support mobile connectivity for carriers and other customers. By concentrating on its tower portfolio and exiting the fiber and small-cell segment, the company is...

In late June 2026, GitLab Inc. was removed from several Russell growth benchmarks and concurrently added to multiple Russell value indices, reflecting a broad reclassification within the index family. This rotation from growth to value benchmarks could materially influence trading flows as passive and benchmark-aware investors adjust their GitLab exposures. We’ll now examine how GitLab’s shift into multiple Russell value indices may affect its existing investment narrative and risk...

The New England Journal of Medicine has retracted the pivotal Tavneos study and, following regulatory concerns over severe liver injuries, both the FDA and European regulators have moved toward withdrawing or revoking the drug’s approval. This rare combination of data integrity questions and potential market rollback raises broader concerns about Amgen’s clinical governance and risk controls in rare disease development. We’ll now examine how the threatened withdrawal of Tavneos may reshape...

Recently, JOYY’s BIGO Ads platform received a 2026 Sales and Marketing Excellence “Sammy” Award for its AI-driven, full-funnel advertising system, while JOYY was again named a “Most Honored Company” in Extel’s 2026 Asia Executive Team Survey for leadership and investor relations. Together, these awards spotlight JOYY’s operational capabilities in AI-powered advertising and its reputation for strong corporate governance and investor communication. We’ll now examine how BIGO Ads’...

Reports that the U.S. government is drafting a rule to ban imports of Chinese-made power inverters put Shoals Technologies Group (SHLS) in focus, as investors weighed how reduced foreign competition might influence its solar equipment business. See our latest analysis for Shoals Technologies Group. Against this policy backdrop, Shoals Technologies Group’s share price has been volatile, with a 1-day share price return of 2.22% and a 30-day share price return down 16.91%. However, a 90-day...

Capricor Therapeutics stock reacts to index removal and regulatory focus Capricor Therapeutics (CAPR) has come into focus after being removed from several Russell indices, just as investors track upcoming U.S. FDA advisory committee discussions on Deramiocel, its Duchenne muscular dystrophy cell therapy candidate. See our latest analysis for Capricor Therapeutics. Capricor Therapeutics shares have come under pressure in the short term, with the stock down 21.82% over seven days and 28.15%...